Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
The Journal of Clinical Investigation
|
October 19, 2020
Functional α6β4 acetylcholine receptor expression enables pharmacological testing of nicotinic agonists with analgesic properties
Daniel Knowland, Shenyan Gu, William A Eckert, et al.
Circulation
|
April 17, 2002
Inhibition of calcineurin and sarcolemmal Ca2+ influx protects cardiac morphology and ventricular function in K(v)4.2N transgenic mice
Rajan Sah, Gavin Y Oudit, The-Tin T Nguyen, et al.
Plos One
|
January 21, 2017
T Cell Subset and Stimulation Strength-Dependent Modulation of T Cell Activation by Kv1.3 Blockers
Wai-Ping Fung-Leung, Wilson Edwards, Yi Liu, et al.
Journal of Medicinal Chemistry
|
December 22, 2009
Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain
Paul C Fritch, Grant McNaughton-Smith, George S Amato, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 11, 2007
Pharmacology and antitussive efficacy of 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic acid (5-trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a transient receptor potential vanilloid 1 antagonist in guinea pigs
Anindya Bhattacharya, Brian P Scott, Nadia Nasser, et al.
The Journal of Biological Chemistry
|
December 25, 2019
Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa<sub>v</sub>1.7
Robert A Neff, Mack Flinspach, Alan Gibbs, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 10, 2011
Discovery of a novel series of selective HCN1 blockers
Kelly J McClure, Michael Maher, Nancy Wu, et al.
British Journal of Pharmacology
|
July 30, 2013
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567
Anindya Bhattacharya, Qi Wang, Hong Ao, et al.
The Journal of Biological Chemistry
|
June 14, 2013
Analysis of the structural and molecular basis of voltage-sensitive sodium channel inhibition by the spider toxin huwentoxin-IV (μ-TRTX-Hh2a)
Natali A Minassian, Alan Gibbs, Amy Y Shih, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 6, 2016
The discovery and preclinical characterization of 6-chloro-N-(2-(4,4-difluoropiperidin-1-yl)-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethyl)quinoline-5-carboxamide based P2X7 antagonists
Jason C Rech, Anindya Bhattacharya, Bryan J Branstetter, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
The Journal of Clinical Investigation
|
October 19, 2020
Functional α6β4 acetylcholine receptor expression enables pharmacological testing of nicotinic agonists with analgesic properties
Daniel Knowland, Shenyan Gu, William A Eckert, et al.
Circulation
|
April 17, 2002
Inhibition of calcineurin and sarcolemmal Ca2+ influx protects cardiac morphology and ventricular function in K(v)4.2N transgenic mice
Rajan Sah, Gavin Y Oudit, The-Tin T Nguyen, et al.
Plos One
|
January 21, 2017
T Cell Subset and Stimulation Strength-Dependent Modulation of T Cell Activation by Kv1.3 Blockers
Wai-Ping Fung-Leung, Wilson Edwards, Yi Liu, et al.
Journal of Medicinal Chemistry
|
December 22, 2009
Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain
Paul C Fritch, Grant McNaughton-Smith, George S Amato, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 11, 2007
Pharmacology and antitussive efficacy of 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic acid (5-trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a transient receptor potential vanilloid 1 antagonist in guinea pigs
Anindya Bhattacharya, Brian P Scott, Nadia Nasser, et al.
The Journal of Biological Chemistry
|
December 25, 2019
Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa<sub>v</sub>1.7
Robert A Neff, Mack Flinspach, Alan Gibbs, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 10, 2011
Discovery of a novel series of selective HCN1 blockers
Kelly J McClure, Michael Maher, Nancy Wu, et al.
British Journal of Pharmacology
|
July 30, 2013
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567
Anindya Bhattacharya, Qi Wang, Hong Ao, et al.
The Journal of Biological Chemistry
|
June 14, 2013
Analysis of the structural and molecular basis of voltage-sensitive sodium channel inhibition by the spider toxin huwentoxin-IV (μ-TRTX-Hh2a)
Natali A Minassian, Alan Gibbs, Amy Y Shih, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 6, 2016
The discovery and preclinical characterization of 6-chloro-N-(2-(4,4-difluoropiperidin-1-yl)-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethyl)quinoline-5-carboxamide based P2X7 antagonists
Jason C Rech, Anindya Bhattacharya, Bryan J Branstetter, et al.
Page
of 5